|
BRKR
|
Bruker Corporation
|
12.76%
|
US
|
NASDAQ
|
|
BEAM
|
Beam Therapeutics Inc.
|
10.79%
|
US
|
NASDAQ
|
|
BNGO
|
Bionano Genomics, Inc.
|
5.13%
|
US
|
NASDAQ
|
|
ARCT
|
Arcturus Therapeutics Ltd.
|
4.79%
|
US
|
NASDAQ
|
|
LQDA
|
Liquidia Technologies, Inc.
|
4.42%
|
US
|
NASDAQ
|
|
NNDM
|
Nano Dimension Ltd.
|
3.98%
|
US
|
NASDAQ
|
|
ALKS
|
Alkermes plc
|
3.25%
|
US
|
NASDAQ
|
|
JAZZ
|
Jazz Pharmaceuticals plc
|
3.03%
|
US
|
NASDAQ
|
|
ANGO
|
AngioDynamics, Inc.
|
3.02%
|
US
|
NASDAQ
|
|
KLAC
|
KLA-Tencor Corporation
|
2.98%
|
US
|
NASDAQ
|
|
ALNY
|
Alnylam Pharmaceuticals, Inc.
|
2.91%
|
US
|
NASDAQ
|
|
AME
|
AMETEK, Inc.
|
2.91%
|
US
|
NYSE
|
|
TMO
|
Thermo Fisher Scientific Inc
|
2.82%
|
US
|
NYSE
|
|
IEX
|
IDEX Corporation
|
2.80%
|
US
|
NYSE
|
|
MRNA
|
Moderna, Inc.
|
2.78%
|
US
|
NASDAQ
|
|
LITE
|
Lumentum Holdings Inc.
|
2.76%
|
US
|
NASDAQ
|
|
LRCX
|
Lam Research Corporation
|
2.74%
|
US
|
NASDAQ
|
|
DHR
|
Danaher Corporation
|
2.72%
|
US
|
NYSE
|
|
CBT
|
Cabot Corporation
|
2.72%
|
US
|
NYSE
|
|
PDSB
|
PDS Biotechnology Corporation
|
2.62%
|
US
|
NASDAQ
|